Middle East and North Africa

Diabetes report 2000 — 2045

Estimates were made for 21 countries and territories in the IDF Middle East and North Africa (MENA) Region. A total of 31 data sources from 18 countries were used to estimate diabetes prevalence in 20-79 year-old adults in the Region. Afghanistan, Bahrain, Egypt, Jordan, Lebanon, Morocco, Pakistan and Tunisia had studies conducted within the past five years.

MENA Region has the highest regional prevalence of 16.2% and the second highest expected increase (86%) in the number of people with diabetes reaching 136 million by 2045. The MENA Region has the highest percentage (24.5%) of diabetes-related deaths in people of working age. Only 32.6 billion USD was spent on diabetes in MENA Region, representing 3.4% of the total spent worldwide, despite the region being home to 13.6% of people with diabetes worldwide.

Key Messages


An approximate 55 million adults aged 20–79 years are living with diabetes in the IDF Middle East and North Africa Region. This represents nearly 13% of the regional population in this age group.

The age-adjusted diabetes prevalence is almost 13%: the highest of all IDF Regions.

Close to 45% (25 million) of adults aged 20–79 years with diabetes are undiagnosed.

The number of people with diabetes is expected to increase by almost 39% by 2030 and by 96% by 2045. The second highest increase of all IDF Regions.

The number of adults with impaired glucose tolerance is expected to increase by 33% by 2030, and 82% by 2045.
At a glance 2000 2011 2021 2030 2045
Diabetes estimates (20-79 y)
People with diabetes, in 1,000s 17,007.6 72,671.9 61,425.1 95,000.0 135,700.0
Age-adjusted comparative prevalence of diabetes, % 7.7 11.0 18.1 19.6 20.4
People with undiagnosed diabetes, in 1,000s - - 27,330.5 - -
Proportion of people with undiagnosed diabetes, % - - 37.6 - -

International Diabetes Federation